Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= NRG3 ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: NRG3 * **<color #00a2e8>Official Name</color>**: neuregulin 3 * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10718|10718]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P56975|P56975]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=NRG3&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NRG3|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/605533|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: This gene is a member of the neuregulin gene family. This gene family encodes ligands for the transmembrane tyrosine kinase receptors ERBB3 and ERBB4 - members of the epidermal growth factor receptor family. Ligand binding activates intracellular signaling cascades and the induction of cellular responses including proliferation, migration, differentiation, and survival or apoptosis. This gene encodes neuregulin 3 (NRG3). NRG3 has been shown to activate the tyrosine phosphorylation of its cognate receptor, ERBB4, and is thought to influence neuroblast proliferation, migration and differentiation by signalling through ERBB4. NRG3 also promotes mammary differentiation during embryogenesis. Linkage studies have implicated this gene as a susceptibility locus for schizophrenia and schizoaffective disorder. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described but their biological validity has not been verified.[provided by RefSeq, Sep 2009]. * **<color #00a2e8>UniProt Summary</color>**: Direct ligand for the ERBB4 tyrosine kinase receptor. Binding results in ligand-stimulated tyrosine phosphorylation and activation of the receptor. Does not bind to the EGF receptor, ERBB2 or ERBB3 receptors. May be a survival factor for oligodendrocytes. {ECO:0000269|PubMed:16478787, ECO:0000269|PubMed:9275162}. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |Neuregulin| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |chemorepulsion involved in interneuron migration from the subpallium to the cortex| |directional guidance of interneurons involved in migration from the subpallium to the cortex| |mammary placode formation| |mammary gland formation| |transmembrane receptor protein tyrosine kinase activator activity| |interneuron migration from the subpallium to the cortex| |ectodermal placode formation| |ectodermal placode morphogenesis| |ectodermal placode development| |negative regulation of neuron migration| |substrate-independent telencephalic tangential migration| |substrate-independent telencephalic tangential interneuron migration| |activation of transmembrane receptor protein tyrosine kinase activity| |chemorepellent activity| |regulation of neuron migration| |mammary gland morphogenesis| |negative chemotaxis| |receptor tyrosine kinase binding| |telencephalon cell migration| |forebrain cell migration| |gland morphogenesis| |mammary gland development| |growth factor activity| |telencephalon development| |negative regulation of cell migration| |negative regulation of cell motility| |negative regulation of neurogenesis| |negative regulation of cellular component movement| |negative regulation of nervous system development| |negative regulation of locomotion| |activation of protein kinase activity| |negative regulation of cell development| |signaling receptor binding| |glutamatergic synapse| |forebrain development| |gland development| |regulation of cell growth| |pattern specification process| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |transmembrane receptor protein tyrosine kinase signaling pathway| |positive regulation of protein kinase activity| |chemotaxis| |taxis| |positive regulation of kinase activity| |positive regulation of transferase activity| |regulation of growth| |negative regulation of cell differentiation| |enzyme linked receptor protein signaling pathway| |brain development| |head development| |regulation of protein kinase activity| |regulation of neurogenesis| |cellular protein-containing complex assembly| |regulation of cell migration| |regulation of kinase activity| |anatomical structure formation involved in morphogenesis| |regulation of cell motility| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |animal organ morphogenesis| |cell migration| |regulation of transferase activity| |central nervous system development| |regulation of locomotion| |regulation of cellular component movement| |positive regulation of protein phosphorylation| |positive regulation of phosphorylation| |cell motility| |localization of cell| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |negative regulation of multicellular organismal process| |positive regulation of protein modification process| |locomotion| |integral component of plasma membrane| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |generation of neurons| |movement of cell or subcellular component| |protein-containing complex assembly| |regulation of phosphorylation| |extracellular space| |positive regulation of cellular protein metabolic process| |neurogenesis| |intracellular signal transduction| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |regulation of protein modification process| |protein-containing complex subunit organization| |extracellular region| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp326|CCT251545 20μM R07 exp326]]|1.7| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|1.88| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> No correlation found to any other genes in chemogenomics. </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 15199 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 2.72 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='NRG3 Expression in NALM6 Cells: 2.72'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2026/01/07 22:36by 127.0.0.1